71 related articles for article (PubMed ID: 3444915)
1. The measurement of plasma fibrinopeptide A in breast cancer patients.
Sagripanti A; Carpi A; Ferdeghini M; Pinori E; Nicolini A
Rays; 1987; 12(2):65-9, 107-9. PubMed ID: 3444915
[No Abstract] [Full Text] [Related]
2. Plasma fibrinopeptide A and beta-thromboglobulin in major bacterial infections.
van Hulsteijn H; Fibbe W; Bertina R; Briët E
Thromb Haemost; 1982 Dec; 48(3):247-9. PubMed ID: 6187081
[TBL] [Abstract][Full Text] [Related]
3. Fibrin(ogen) peptides in early breast cancer.
Mannucci PM; Cugno M; Mameli G; Marongiu F; Bianchi Bonomi A
Thromb Haemost; 1989 Sep; 62(2):819. PubMed ID: 2814934
[No Abstract] [Full Text] [Related]
4. [Role of proteases, plasminogen activators, fibrin fibrinogen degradation products and fibrinopeptides in the growth and development of neoplasms and neoplasm metastases].
Farbiszewski R
Postepy Hig Med Dosw; 1984; 38(2):133-55. PubMed ID: 6393101
[No Abstract] [Full Text] [Related]
5. Fibrinopeptide A behaviour in chronic active hepatitis patients.
Violi F; Alessandri C; Ferro D; Gallina G; Iuliano L; Balsano F
Haematologica; 1984; 69(6):655-60. PubMed ID: 6441741
[No Abstract] [Full Text] [Related]
6. Correspondence re: N. C. Denko and A. J. Giaccia, tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis. Cancer Res., 61: 795-798, 2001.
von Tempelhoff GF; Heilmann L; Hommel G
Cancer Res; 2001 Oct; 61(20):7697-8. PubMed ID: 11606414
[No Abstract] [Full Text] [Related]
7. Haemostatic abnormalities and outcome in patients with operable breast cancer.
McCulloch P; Lowe GD; Douglas JT; Murray GD; George WD
Eur J Cancer; 1990; 26(9):950-3. PubMed ID: 2149020
[TBL] [Abstract][Full Text] [Related]
8. [Methodologic studies of the formation of fibrinopeptide A and secretion of platelet factor 4 in coagulating whole blood].
Lorenz R; Gebhart S; Wirth U; Classen M; Heptner W
Med Klin (Munich); 1988 Feb; 83(3):81-7. PubMed ID: 3362102
[No Abstract] [Full Text] [Related]
9. Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease.
Yoda Y; Abe T
Thromb Haemost; 1981 Dec; 46(4):706-9. PubMed ID: 7330820
[TBL] [Abstract][Full Text] [Related]
10. Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer.
Hassan S; Baccarelli A; Salvucci O; Basik M
Clin Cancer Res; 2008 Jan; 14(2):446-54. PubMed ID: 18223219
[TBL] [Abstract][Full Text] [Related]
11. Effects of breast cancer and mastectomy on fibrinolytic activity in African women.
Famodu ES; Fakoya AA; Barhua TA; Osime CO; Egwaikhide E; Egbagbe EE; Olu-Edo AN; Osime EO
Afr J Reprod Health; 2006 Dec; 10(3):114-9. PubMed ID: 17518138
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with operable cervical cancer: influence of surgical-pathological stage, tumor size, histologic type, and lymph node status.
Gadducci A; Baicchi U; Marrai R; Facchini V; del Bravo B; Fosella PV; Fioretti P
Gynecol Oncol; 1993 Jun; 49(3):354-8. PubMed ID: 8314538
[TBL] [Abstract][Full Text] [Related]
13. Monocyte procoagulant activity in breast cancer.
Auger MJ; Mackie MJ
Thromb Res; 1987 Jul; 47(1):77-84. PubMed ID: 3660345
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen degradation products in serum from patients with cancer.
Carlsson S
Acta Chir Scand; 1973; 139(6):499-502. PubMed ID: 4753096
[No Abstract] [Full Text] [Related]
15. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
von Tempelhoff GF; Nieman F; Heilmann L; Hommel G
Clin Hemorheol Microcirc; 2000; 22(2):107-30. PubMed ID: 10831062
[TBL] [Abstract][Full Text] [Related]
16. High fibrinopeptide A (FPA) levels in acute non-lymphocytic leukemia are reduced by heparin administration.
Gugliotta L; Viganò S; D'Angelo A; Guarini A; Tura S; Mannucci PM
Thromb Haemost; 1984 Dec; 52(3):301-4. PubMed ID: 6531754
[TBL] [Abstract][Full Text] [Related]
17. Studies on the functionality of newly synthesized fibrinogen after treatment of acute myocardial infarction with streptokinase, increase in the rate of fibrinopeptide release.
Reganon E; Vila V; Aznar J; Lacueva V; Martinez V; Ruano M
Thromb Haemost; 1993 Dec; 70(6):978-83. PubMed ID: 8165621
[TBL] [Abstract][Full Text] [Related]
18. Elevated fibrinopeptide A levels in patients with clinically localised breast carcinoma.
Auger MJ; Galloway MJ; Leinster SJ; McVerry BA; Mackie MJ
Haemostasis; 1987; 17(6):336-9. PubMed ID: 3428719
[TBL] [Abstract][Full Text] [Related]
19. Fibrin polymerization studied by static and dynamic light-scattering as a function of fibrinopeptide A release.
Wiltzius P; Dietler G; Känzig W; Häberli A; Straub PW
Biopolymers; 1982 Nov; 21(11):2205-23. PubMed ID: 7171733
[No Abstract] [Full Text] [Related]
20. Preeclampsia is not associated with excess fetal clotting.
Weiner C; Keller S
Obstet Gynecol; 1986 Dec; 68(6):871-2. PubMed ID: 3785801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
